Document ID: chunk:federal_register_of_legislation:F2019L01338:reg:9:p2
Version: federal_register_of_legislation:F2019L01338
Segment Type: reg
Provision Reference: reg 9 (pt 2/4)
Character Range: 7003–9840

clinical onset of malignant neoplasm of the renal pelvis or ureter;
            Note 1: Inhaling, ingesting or having cutaneous contact with an aromatic amine does not include exposure due to cigarette smoke or hair dyes.
            Note 2: specified list of aromatic amines is defined in the Schedule 1 – Dictionary.
(6)          inhaling, ingesting or having cutaneous contact with a high concentration of an aromatic amine, through work involving the specified industrial or manufacturing process 2:
(a)          for a cumulative period of at least 1 500 hours, before the clinical onset of malignant neoplasm of the renal pelvis or ureter; and
(b)          where the first exposure occurred at least five years before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
             Note 1:  Inhaling, ingesting or having cutaneous contact with a high concentration of an aromatic amine does not include exposure due to cigarette smoke or hair dyes.
             Note 2: specified industrial or manufacturing process 2 is defined in the Schedule 1 – Dictionary.
(7)          inhaling, ingesting or having cutaneous contact with tetrachloroethylene for a cumulative period of at least 5 000 hours, before the clinical onset of malignant neoplasm of the renal pelvis or ureter, where the first exposure occurred at least five years before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
(8)          being heavily exposed to diesel engine exhaust for a cumulative period of at least 15 000 hours, before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
            Note: being heavily exposed to diesel engine exhaust is defined in the Schedule 1 – Dictionary.
(9)          being exposed to lead as specified before the clinical onset of malignant neoplasm of the renal pelvis or ureter, where the first exposure to lead occurred at least five years before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
            Note: being exposed to lead as specified is defined in the Schedule 1 – Dictionary.
(10)      being exposed to arsenic as specified before the clinical onset of malignant neoplasm of the renal pelvis or ureter, where the first exposure to arsenic occurred at least ten years before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
Note: being exposed to arsenic as specified is defined in the Schedule 1 – Dictionary.
(11)      working as a painter for a cumulative period of at least 5 000 hours, before the clinical onset of malignant neoplasm of the renal pelvis or ureter, where that work began at least five years before the clinical onset of malignant neoplasm of the renal pelvis or ureter;
             Note: working as a painter is defined in the Schedule 1 – Dictionary.
(12)      working as a